fda warning on semaglutide The has received reports of adverse events after patients used compounded versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved The FBI is warning the

The evidence for these is less robust than for simethicone, but many users report subjective improvement

But after clinical trails showed its promising effects on weight loss, in 2021, the FDA approved semaglutide (Wegovy), a once-weekly injection, for weight loss in adults when used in combination with a healthy diet and routine exercise

Most Wegovy side effects are temporary and improve within a few weeks as your body adjusts to the medication

Typical Wegovy timeline: Weeks 1-4 (0.25mg): Starting dose hunger will decrease but may effects may wear off after 4-5 days post injection Weeks 5-8 (0.5mg): First increase hunger should feel more consistently lower, but effects may still wear off close to your next injection Weeks 9-12 (1.0mg): Second increase hunger lowering effect should be stronger at this stage, and the drug should have reached its steady state and have a more stable effect Weeks 13-16 (1.7mg): Third increase significantly lower hunger and food cravings without dips in hunger levels between injections Weeks 17+ (2.4mg): Maintenance dose stable hunger levels with low food cravings Based on clinical trial data, you can expect to lose up to 5% of your weight in the first month on Wegovy and up to 8% after two months